This information is accurate as of 04/6/2026. Please refer back to the website to ensure all reference information is current and up-to-date.

ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years

February 3, 2022
|In Show all, COVID-19, External News
|By Alice Black

The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years.

Evidence demonstrates that waning of protection against the Omicron variant occurs after a two-dose primary vaccination schedule and a booster dose is required to increase protection against infection and severe disease.

This statement addresses the safety, efficacy and epidemiological considerations.

Follow the link below to read the recommendations in full:
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Latest news

June 4, 2026

NIP: Adult pneumococcal vaccination – Program advice for health professionals
June 4, 2026

Immunisation Coalition: Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Share This